Andre Kraft
Bedrijfssecretaris bij Bymax Corp.
Vermogen: 10 $ op 31-07-2021
Oorsprong van het eerstegraads netwerk van Andre Kraft
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Ruprecht-Karls-Universität Heidelberg
8
| College/University | Other Consumer Services | 8 |
Bymax Corp.
2
| Unknown | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andre Kraft via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
COMMERZBANK AG | Regional Banks | Director/Board Member | |
JENOPTIK AG | Electronic Components | Director/Board Member | |
Deutsche Bahn AG
Deutsche Bahn AG RailroadsTransportation Deutsche Bahn AG engages in the provision of mobility, logistics, and passenger transport services. It operates through the following segments: DB Long-Distance, DB Regional, DB Arriva, DB Cargo, DB Schenker, DB Netze bStations, and DB Netza Energy. The company was founded in 1994 and is headquartered in Berlin, Germany. | Railroads | Director/Board Member | |
CEWE STIFTUNG & CO. KGAA | Specialty Stores | Director/Board Member | |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
Roche Glycart AG
Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Universität des Saarlandes | College/University | Doctorate Degree | |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
University of Hagen | College/University | Undergraduate Degree | |
Philipps University of Marburg | College/University | Undergraduate Degree | |
International Intra-Ocular Implant Club
International Intra-Ocular Implant Club Miscellaneous Commercial ServicesCommercial Services The International Intra-Ocular Implant Club is a research organization that focuses on the field of intraocular lens implantation. | Miscellaneous Commercial Services | President | |
American Academy of Ophthalmology, Inc.
American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Martin-Luther-Universität Halle-Wittenberg | College/University | Graduate Degree | |
The American Society of Cataract & Refractive Surgery | Corporate Officer/Principal | ||
International Society of Refractive Surgery
International Society of Refractive Surgery Miscellaneous Commercial ServicesCommercial Services Part of American Academy of Ophthalmology, Inc., International Society of Refractive Surgery (ISRS) is an international society that focuses on refractive surgery. The company is based in San Francisco, CA. ISRS offers various resources such as meetings, webinars, and a multimedia library to its members. Members can also benefit from discounts on editing services for the Journal of Refractive Surgery and article processing charges for open-access articles. ISRS also provides an externship program for members to work alongside world-renowned refractive and cataract surgeons. The company hosts an annual meeting, the Refractive Surgery Subspecialty Day, where members can learn about the latest topics in cataract, refractive, and lens-based surgery. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Orthocon, Inc.
Orthocon, Inc. Medical SpecialtiesHealth Technology Orthocon, Inc. designs, develops, and markets medical implantable devices. It provides implantable products designed to stop bone bleeding. The company was founded in 2005 and is headquartered in Irvington, NY. | Medical Specialties | Director/Board Member | |
Heilongjiang University | College/University | Undergraduate Degree | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
Shanghai University | College/University | Graduate Degree | |
KPMG AG Wirtschaftsprüfungsgesellschaft
KPMG AG Wirtschaftsprüfungsgesellschaft Miscellaneous Commercial ServicesCommercial Services KPMG AG Wirtschaftsprüfungsgesellschaft engages in the provision of auditing services. It also offers tax, consulting, deal advisory, and financial services. The firm focuses on various sectors such as automotive, pharmaceutical, energy, financial services, media, healthcare, industrial manufacturing, and telecommunications sectors. The company is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Natural Dental Implants AG
Natural Dental Implants AG Medical SpecialtiesHealth Technology Natural Dental Implants AG provides dental technology products and services. The firm specialized in the development of Replicate, a non-surgical tooth replacement system designed to alternative preserve alveolar bone and adjacent teeth. It offers an alternative solutions to traditional dental implants and three unit dental bridges, with focus on three-dimensional image and impression, natural healing, and temporary and permanent crown features. The company was founded by Ruedger Rubbert and Lea Ellermeier Nesbit in 2009 and is headquartered in Berlin, Germany. | Medical Specialties | Director/Board Member | |
The European Society of Cataract & Refractive Surgeons
The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services The European Society of Cataract & Refractive Surgeons, founded in 1991, presents "The Innovators Den: EyeCare Pioneers" at ESCRS iNovation® Day 2023. The non-profit company is based in Dublin, IE and has subsidiaries in United Kingdom. Applications for the event are now open. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of North Carolina at Charlotte | College/University | Graduate Degree | |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chief Executive Officer | |
Ernst & Young GmbH Wirtschaftsprufungsgesellschaft
Ernst & Young GmbH Wirtschaftsprufungsgesellschaft Miscellaneous Commercial ServicesCommercial Services Ernst & Young GmbH Wirtschaftsprufungsgesellschaft, also known as EY, is a German company that provides financial services consulting and EHS (Environment, Health, and Safety) risk management solutions. The private company is based in Berlin, Germany. The company's EY CCaSS teams specialize in reducing the risk of EHS incidents and supporting decision-making to improve outcomes associated with EHS. The company also helps businesses refine their strategy in this transformative age. | Miscellaneous Commercial Services | Director/Board Member | |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Chief Executive Officer | |
German Ophthalmological Society | Corporate Officer/Principal | ||
Medical Faculty Mannheim | College/University | Corporate Officer/Principal | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
VSDAR eV | Founder | ||
EUROEYES INTERNATIONAL EYE CLINIC LIMITED | Medical/Nursing Services | Corporate Officer/Principal | |
Tridek-One Therapeutics SAS
Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member | |
Kommission Refraktive Chirurgie | Corporate Secretary | ||
Freevis Lasik Center Mannheim GmbH | Chief Executive Officer | ||
Asia Pacific Association of Cataract & Refractive Surgeons | Corporate Officer/Principal | ||
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Shingao International Ltd. | Corporate Officer/Principal | ||
Die Autobahn GmbH des Bundes
Die Autobahn GmbH des Bundes Miscellaneous Commercial ServicesCommercial Services Die Autobahn GmbH des Bundes is a German company that engages in the planning, construction, operation, maintenance, and financing of motorways. The private company is based in Berlin, Germany. The CEOs are Gunther Adler, Anne Rethmann. The company was founded in 2018. | Miscellaneous Commercial Services | Director/Board Member | |
FreeVis LASIK Zentrum Mannheim GmbH
FreeVis LASIK Zentrum Mannheim GmbH Medical/Nursing ServicesHealth Services FreeVis LASIK Zentrum Mannheim GmbH engages in the operation of an eye clinic. It offers services such as vision correction, refractive laser procedures, and lens implants. The company was founded by Michael Christian Knorz in 1993 and is headquartered in Mannheim, Germany. | Medical/Nursing Services | Chief Executive Officer | |
European Center For Board Efficiency Ecbe GmbH | Corporate Officer/Principal | ||
Yunex GmbH
Yunex GmbH Packaged SoftwareTechnology Services Part of Mundys SpA, Yunex GmbH is a German company that specializes in advanced road pricing technology for intelligent demand management, tolling of interurban roads, national tolling systems, city toll, ANPR, GNSS, and OBUs. The company is based in Munich, Germany. The company aims to make traffic infrastructure safer, greener, and more efficient worldwide with cutting-edge digital technology. Yunex provides intelligent solutions for connected mobility powered by data analytics and artificial intelligence (AI), including connected vehicles and connected infrastructure systems. The company was founded in 2019, and Markus Schlitt has been the CEO of the company since 2021. Yunex was acquired by Mundys SpA from Siemens AG on June 30, 2022 for $1,086.18 million. | Packaged Software | Director/Board Member | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman |
Statistieken
Internationaal
Duitsland | 25 |
Zwitserland | 8 |
Verenigde Staten | 7 |
Nederland | 5 |
China | 4 |
Sectoraal
Health Technology | 14 |
Commercial Services | 10 |
Consumer Services | 8 |
Health Services | 5 |
Finance | 4 |
Operationeel
Director/Board Member | 26 |
Corporate Officer/Principal | 22 |
Chief Executive Officer | 8 |
Doctorate Degree | 7 |
Undergraduate Degree | 7 |
Sterkste connecties
Insiders | |
---|---|
Klaus Breiner | 16 |
Michael Christian Knorz | 15 |
Daniela Mattheus | 12 |
Marcus Furch | 11 |
Xiao Hong Han | 5 |
Melanie Rolli | 5 |
Long Jiang Li | 3 |
Zhongqing Zhang | 3 |
David Richter | 2 |
Mumin Demiral | 2 |
- Beurs
- Insiders
- Andre Kraft
- Bedrijfsconnecties